FBXO29 Antibodies

Santa Cruz Biotechnology features a diverse variety of FBXO29 monoclonal antibodies for advanced research in cellular biology. FBXO29 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBXO29 is a member of the F-box protein family, which plays a significant role in the ubiquitin-proteasome pathway, a key mechanism for protein degradation and regulation within the cell. FBXO29 is involved in the modulation of various cellular processes, including cell cycle progression and signal transduction, making it essential for maintaining cellular homeostasis. Understanding FBXO29 function can provide insights into its implications in various diseases, including cancer and neurodegenerative disorders. Researchers worldwide rely on FBXO29 monoclonal antibodies to advance their understanding of cellular mechanisms and pathways. Current investigations focus on revealing FBXO29's role in disease progression and potential therapeutic applications. FBXO29 monoclonal antibodies enable precise detection and analysis of protein expression patterns across different experimental conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers in their mission to advance scientific knowledge and develop innovative therapeutic strategies.